Smartphone mechanocardiography used for post-ablation home monitoring to detect atrial fibrillation recurrence: usability, adherence, and re-ablation

European Heart Journal - Digital Health

29 October 2026
Organised by: Logo
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY CARDIOVASCULAR NURSING AND ALLIED PROFESSIONS Public Health and Health Economics Research Methodology Atrial Fibrillation (AF) Interventional Cardiology PREVENTIVE CARDIOLOGY Rehabilitation and Sports Cardiology Risk Factors and Prevention

Abstract

AbstractAims

Recurrence of atrial fibrillation (AF) following catheter ablation is common but may be underdetected using conventional intermittent monitoring. Smartphone-based mechanocardiography (MCG) enables low-burden rhythm assessment; however, evidence regarding its real-world applicability in the post-ablation setting remains limited. We aimed to evaluate the feasibility, usability, and clinical relevance of MCG-based home monitoring after AF ablation, and to explore its association with re-ablation.

Methods and results

In this prospective single-centre study, 640 consecutive patients with paroxysmal and persistent AF undergoing AF ablation were offered home monitoring using the CardioSignal smartphone application. Among these, 521 (81%) were active users during the first month, and 354 (68%) remained active at 6 months. 8240 recordings were performed in the first month, declining to 2869 at 6 months. AF recurrence was detected in 40% of active users during the first 3 months and in 30% during months 4–6, with clear early clustering. Usability was high: 95% of survey respondents (n = 338) reported the app was easy to use, and 91% perceived monitoring as valuable. In a predefined Danish sub-cohort (n = 164), Kaplan–Meier survival analysis demonstrated early AF recurrence detected by MCG was strongly associated with re-ablation within 12 months (log-rank P < 0.0002), occurring in 27.6% of patients with early AF recurrence vs. 4.5% without.

Conclusion

Smartphone-based MCG is a feasible, well-accepted method for patient-initiated, low-burden event monitoring. Early AF recurrence detected by MCG is common and associated with re-ablation, supporting its role in early risk stratification and post-procedural management.